Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease


Partnerships that make a difference

In our efforts to bring the best possible eye care to patients across the globe, ThromboGenics can count on a network of experienced partners. These strategic partnerships include research collaborations, co-development and co-commercialization as well as in-licensing agreements.

Our goal is to be a market leader in the development and commercialization of innovative ophthalmologic drugs. We are committed to achieving this through the internal development of drugs, by in-licensing high-potential, early-stage compounds, and by continuing to advance them through the clinical development, regulatory approval and commercial introduction processes.

How to partner with ThromboGenics

At ThromboGenics, we always keep an open mind to new opportunities for partnership and collaboration with the aim of improving eye care, particularly to the diabetic population, and through the further development of the clinical applications of JETREA® (ocriplasmin).

Interested in teaming up with a leading biopharmaceutical company? Please drop us a line via and share your ideas or questions. You can count on our timely and well-considered response.